<DOC>
	<DOCNO>NCT00905502</DOCNO>
	<brief_summary>The objective study evaluate effect 'high ' versus 'low ' volume intraoperative fluid administration ( Ringer Lactate , RL ) intra- postoperative parameter , obese patient undergo laparoscopic bariatric surgery ( i.e. , gastric bypass ) , order establish evidence-based data perioperative fluid management patient population . Based experience well several report literature , investigator hypothesize restrictive approach intraoperative hydration reduce incidence postoperative complication recovery time gastrointestinal ( GI ) function , shorten hospital stay .</brief_summary>
	<brief_title>Intraoperative Fluid Management Laparoscopic Bariatric Surgery</brief_title>
	<detailed_description>Obesity , chronic disease increase prevalence adult , adolescent , child , consider global epidemic . The prevalence obesity increase markedly last two decade consider global epidemic . In US 65 % adult overweight obese 30 % obese . Surgery effective treatment morbid obesity , open Roux-en-Y gastric bypass ( RYGB ) become procedure choice patient . Several study perioperative fluid management report 'high volume ' regimen may result overhydration deleterious effect cardiac pulmonary function , recovery GI motility , tissue oxygenation , wound heal coagulation . Most reported randomized trial suggest perioperative fluid management evolve restricted regimen . Specifically , restrict fluid volume apply bariatric procedure show reduce perioperative complication ( pulmonary dysfunction , hypoxia , nausea vomit ) , thereby decrease prevalence morbidity mortality associate procedure . We wish evaluate prospective randomize study impact fluid management perioperative parameter patient undergo variety laparoscopic bariatric procedure : Roux-Y Gastric Bypass ( LRYGB ) , Biliopancreatic Diversion Duodenal Switch ( LDS ) , Sleeve Gastrectomy ( LSG ) . Patients randomly allocate one two group receive either 4 ml/kg•hr 10 ml/kg•hr RL solution throughout intra-operative period . The primary endpoint study include : mortality rate incidence postoperative complication , primary hospitalization . Readmission rate hospital within 30 day surgery another primary endpoint . The secondary endpoint include time till patient resume drink consume soft food , length hospital stay , difference hematocrit , creatinine concentration oxygen saturation first third postoperative day discharge , number patient receive transfusion blood blood product .</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Abdominal Abscess</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Adult patient ( &gt; 18 year ) American Society Anesthesiology physical status IIII present laparoscopic bariatric surgery , prospectively study . Patients consider eligible BMI &gt; 40 , &gt; 35 least one comorbid condition schedule undergo one follow laparoscopic operation : RouxY Gastric Bypass ( LRYGB ) Biliopancreatic Diversion Duodenal Switch ( LDS ) , Sleeve Gastrectomy ( LSG ) . Patients age young 18 year . Patients renal dysfunction ( creatinine &gt; 50 % upper limit normal value ) . Congestive heart failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Obesity</keyword>
	<keyword>fluid management</keyword>
	<keyword>postoperative complication</keyword>
	<keyword>bariatric surgery</keyword>
	<keyword>hemostasis</keyword>
</DOC>